Australian Clinical Labs Limited (ACL.AX)
AUD 3.49
(-3.32%)
AUD 3.49
(-3.32%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 159.59 Million | 143.68 Million | 284.08 Million | 153.86 Million | 101.73 Million | 1.11 Million |
| Net Income | 23.93 Million | 35.9 Million | 178.24 Million | 60.37 Million | 41.25 Million | -10.52 Million |
| Depreciation & Amortization | 128.42 Million | 122.75 Million | 106.09 Million | 88.05 Million | 77.9 Million | 11.5 Million |
| Deferred income taxes | - | -1.88 Million | -1.45 Million | -2.16 Million | -168 Million | -30.44 Million |
| Stock-based compensation | 3.06 Million | 1.88 Million | 1.45 Million | 2.16 Million | 323 Thousand | 321 Thousand |
| Change in working capital | 487 Thousand | -6.24 Million | -10.51 Million | 13 Million | -11.53 Million | -5.07 Million |
| Other non-cash items | 261.4 Million | -8.73 Million | 10.26 Million | -7.56 Million | 161.8 Million | 35.32 Million |
| Investing Cash Flow | -7.24 Million | -12.18 Million | -72.04 Million | -6.07 Million | -9.95 Million | -13.37 Million |
| Investments in PPE | -6.5 Million | -6.93 Million | -21.25 Million | -9.5 Million | -9.38 Million | -14.36 Million |
| Acquisitions | -742 Thousand | -5.24 Million | -50.79 Million | 2.36 Million | 110 Thousand | 1.36 Million |
| Investment purchases | - | - | - | -2.36 Million | -687 Thousand | -527 Thousand |
| Sales/Maturities of investments | - | - | - | 1.06 Million | -110 Thousand | 150 Thousand |
| Other Investing Activities | 325 Thousand | -5.48 Million | -51.06 Million | 2.36 Million | 110 Thousand | 303 Thousand |
| Financing Cash Flow | -146.13 Million | -137.87 Million | -220.91 Million | -147.37 Million | -60.91 Million | 9.52 Million |
| Debt repayment | -11 Million | -34.5 Million | -100 Million | -269.59 Million | -60.91 Million | -4.88 Million |
| Dividends payments | -19.94 Million | -96.88 Million | -24.21 Million | -42 Million | - | - |
| Common Stock Repurchased | -1.74 Million | -891 Thousand | -4.94 Million | 321.6 Million | - | -527 Thousand |
| Common Stock Issuance | - | 100.5 Million | - | 146.25 Million | - | 14.41 Million |
| Other Financing Activities | -388 Thousand | -106.1 Million | -91.68 Million | -303.63 Million | - | 16.79 Million |
| Accounts receivables | -7.72 Million | 17.4 Million | -28.11 Million | 2.74 Million | -16.8 Million | -3.76 Million |
| Accounts payables | 11.65 Million | -17.72 Million | 16.48 Million | 5.17 Million | 5.74 Million | -2.91 Million |
| Inventory | -1.73 Million | 4.99 Million | -3.89 Million | -2.26 Million | -828 Thousand | -423 Thousand |
| Other working capital | -1.7 Million | -10.91 Million | 5.01 Million | 7.34 Million | 343 Thousand | 2.02 Million |
| Cash at beginning of period | 19.95 Million | 26.37 Million | 35.23 Million | 34.84 Million | 4.13 Million | 6.86 Million |
| Cash at end of period | 26.13 Million | 19.95 Million | 26.37 Million | 35.23 Million | 34.84 Million | 4.13 Million |
| Capital Expenditure | -6.5 Million | -6.93 Million | -21.25 Million | -9.5 Million | -9.38 Million | -14.36 Million |
| Effect of forex changes on cash | -25 Thousand | -40 Thousand | 5000.00 | -34 Thousand | -144 Thousand | 4000.00 |
| Net cash flow / Change in cash | 6.18 Million | -6.41 Million | -8.86 Million | 384 Thousand | 30.71 Million | -2.73 Million |
| Free Cash Flow | 153.08 Million | 136.74 Million | 262.83 Million | 144.35 Million | 92.35 Million | -13.25 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.49 Million | 23.93 Million | 9.49 Million | 4.95 Million | 2.47 Million | 10.48 Million |
| Depreciation & Amortization | 32.36 Million | 128.42 Million | 32.36 Million | 63.7 Million | 31.85 Million | 61.89 Million |
| Deferred income taxes | - | - | - | - | - | -130.48 Million |
| Stock-based compensation | 1.53 Million | - | 1.53 Million | - | - | 941.5 Thousand |
| Change in working capital | -5.58 Million | 487 Thousand | -5.58 Million | - | - | 5.74 Million |
| Other non-cash items | 5.22 Million | 261.4 Million | 5.22 Million | 132.28 Million | 2.43 Million | 131.83 Million |
| Investing Cash Flow | 1.9 Million | -7.24 Million | 1.9 Million | -11.06 Million | -5.53 Million | -8.53 Million |
| Investments in PPE | -1.34 Million | -6.5 Million | -1.34 Million | -3.82 Million | -1.91 Million | -3.3 Million |
| Acquisitions | -272 Thousand | -742 Thousand | -272 Thousand | -258 Thousand | -261.5 Thousand | -5.23 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3.52 Million | - | 3.52 Million | -6.98 Million | -3.35 Million | 72.5 Thousand |
| Financing Cash Flow | -44.33 Million | -146.13 Million | -44.33 Million | -57.47 Million | -28.73 Million | -67.99 Million |
| Debt repayment | -24 Million | -11 Million | - | -13 Million | - | - |
| Dividends payments | -5.82 Million | -19.94 Million | -2.91 Million | -14.12 Million | -7.06 Million | -14.15 Million |
| Common Stock Repurchased | -871 Thousand | -1.74 Million | -871 Thousand | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -40.55 Million | -388 Thousand | -40.55 Million | -175 Thousand | -21.67 Million | -26.92 Million |
| Accounts receivables | -3.86 Million | -7.72 Million | -3.86 Million | - | - | 8.7 Million |
| Accounts payables | - | 11.65 Million | - | - | - | - |
| Inventory | -867 Thousand | -1.73 Million | -867 Thousand | - | - | 2.49 Million |
| Other working capital | -852.5 Thousand | -1.7 Million | -852.5 Thousand | - | - | -5.45 Million |
| Cash at beginning of period | 24.93 Million | 19.95 Million | - | 19.95 Million | - | 16.13 Million |
| Cash at end of period | 26.13 Million | 26.13 Million | 599 Thousand | 24.93 Million | 2.49 Million | 19.95 Million |
| Capital Expenditure | -1.34 Million | -6.5 Million | -1.34 Million | -3.82 Million | -1.91 Million | -3.3 Million |
| Effect of forex changes on cash | -6000.00 | - | -6000.00 | -6500.00 | -6500.00 | -32.5 Thousand |
| Net cash flow / Change in cash | 1.19 Million | 6.18 Million | 599 Thousand | 4.98 Million | 2.49 Million | 3.82 Million |
| Free Cash Flow | 41.68 Million | 153.08 Million | 41.68 Million | 69.7 Million | 34.85 Million | 77.11 Million |
BRBR
4162
1448
RSRV
XP
BPHLF